New perspectives on insulin therapy
Open Access
- 31 March 2020
- journal article
- research article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 11 (4), 795-797
- https://doi.org/10.1111/jdi.13263
Abstract
Insulin was discovered by Banting and Best in 1921, and was subsequently applied for the treatment of diabetes. Porcine or bovine insulin purified from their pancreas had been used clinically for more than 50 years until the development of the methods to produce recombinant human insulin by genetical engineering techniques. The Diabetes Control and Complications Trial (DCCT) (1) and our Kumamoto Study (2) provided the evidences that better glycemic control could be obtained by intensive insulin therapy consisted of the supplementation of both basal and postprandial insulin, which in turn resulted in the prevention of the initiation and progression of diabetic microvascular complications.Keywords
This publication has 15 references indexed in Scilit:
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020Diabetes Care, 2019
- Response to insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?Journal of Diabetes Investigation, 2019
- Insulin degludec and insulin glargine 300 U/ mL : Which of these two insulins causes less hypoglycemia?Journal of Diabetes Investigation, 2019
- More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT TrialDiabetes Care, 2018
- Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross‐over studyJournal of Diabetes Investigation, 2018
- Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open‐label, cross‐over study using continuous glucose monitoring profilesJournal of Diabetes Investigation, 2018
- Effects of sodium–glucose cotransporter 2 inhibitors in addition to insulin therapy on cardiovascular risk factors in type 2 diabetes patients: A meta‐analysis of randomized controlled trialsJournal of Diabetes Investigation, 2018
- Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysisJournal of Diabetes Investigation, 2017
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993